<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:23:58Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8035596" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8035596</identifier>
        <datestamp>2021-04-12</datestamp>
        <setSpec>trials</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="letter">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Trials</journal-id>
              <journal-id journal-id-type="iso-abbrev">Trials</journal-id>
              <journal-title-group>
                <journal-title>Trials</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1745-6215</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8035596</article-id>
              <article-id pub-id-type="pmcid">PMC8035596</article-id>
              <article-id pub-id-type="pmc-uid">8035596</article-id>
              <article-id pub-id-type="pmid">33838678</article-id>
              <article-id pub-id-type="publisher-id">5226</article-id>
              <article-id pub-id-type="doi">10.1186/s13063-021-05226-4</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Letter</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title><italic>Supporting Parents &amp; Kids Through Lockdown Experiences (SPARKLE)</italic>: A digital parenting support app implemented in an ongoing general population cohort study during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kostyrka-Allchorne</surname>
                    <given-names>Katarzyna</given-names>
                  </name>
                  <address>
                    <email>kasia.kostyrka-allchorne@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Creswell</surname>
                    <given-names>Cathy</given-names>
                  </name>
                  <address>
                    <email>cathy.creswell@psych.ox.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Byford</surname>
                    <given-names>Sarah</given-names>
                  </name>
                  <address>
                    <email>sarah.byford@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Day</surname>
                    <given-names>Crispin</given-names>
                  </name>
                  <address>
                    <email>crispin.1.day@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Goldsmith</surname>
                    <given-names>Kimberley</given-names>
                  </name>
                  <address>
                    <email>kimberley.goldsmith@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Koch</surname>
                    <given-names>Marta</given-names>
                  </name>
                  <address>
                    <email>marta.koch@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gutierrez</surname>
                    <given-names>Walter Muruet</given-names>
                  </name>
                  <address>
                    <email>walter.muruet_gutierrez@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Palmer</surname>
                    <given-names>Melanie</given-names>
                  </name>
                  <address>
                    <email>melanie.palmer@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Raw</surname>
                    <given-names>Jasmine</given-names>
                  </name>
                  <address>
                    <email>Jasmine.Raw@pgr.reading.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Robertson</surname>
                    <given-names>Olly</given-names>
                  </name>
                  <address>
                    <email>olly.robertson@psych.ox.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shearer</surname>
                    <given-names>James</given-names>
                  </name>
                  <address>
                    <email>james.shearer@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shum</surname>
                    <given-names>Adrienne</given-names>
                  </name>
                  <address>
                    <email>hei.shum@psych.ox.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Slovak</surname>
                    <given-names>Petr</given-names>
                  </name>
                  <address>
                    <email>petr.slovac@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Waite</surname>
                    <given-names>Polly</given-names>
                  </name>
                  <address>
                    <email>polly.waite@psych.ox.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Sonuga-Barke</surname>
                    <given-names>Edmund J. S.</given-names>
                  </name>
                  <address>
                    <email>edmund.sonuga-barke@kcl.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>Institute of Psychiatry, Psychology &amp; Neuroscience, </institution><institution>King’s College London, </institution></institution-wrap>London, UK </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution>Departments of Psychiatry and Experimental Psychology, </institution><institution>University of Oxford, </institution></institution-wrap>Oxford, UK </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>10</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>10</day>
                <month>4</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>22</volume>
              <elocation-id>267</elocation-id>
              <history>
                <date date-type="received">
                  <day>24</day>
                  <month>3</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>26</day>
                  <month>3</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2021</copyright-statement>
                <license>
                  <ali:license_ref specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Objectives</title>
                  <p id="Par1">The COVID-19 related lockdowns and distancing measures have presented families with unprecedented challenges. A UK-wide cohort study tracking changes in families’ mental health since early lockdown (Co-SPACE) found a significant rise in primary school-aged children’s behaviour problems and associated family-related stress. Three-quarters of parents in Co-SPACE also reported wanting extra support. In SPARKLE, we will examine whether providing Co-SPACE families with a smartphone application delivering information and parenting support, <italic>Parent Positive,</italic> can reverse the negative effects of the pandemic on children and parents. The efficacy on child and parent outcomes and cost-effectiveness of <italic>Parent Positive</italic> will be examined. We will also test whether the effects are moderated by pre-existing levels of child conduct problems and usage of <italic>Parent Positive</italic>. Exploratory analyses will examine whether other baseline characteristics or lockdown circumstances moderate the effects of <italic>Parent Positive</italic>.</p>
                </sec>
                <sec>
                  <title>Trial design</title>
                  <p id="Par2">SPARKLE is a two-arm superiority parallel group randomised controlled trial embedded in an existing large UK-wide self-selected community cohort – Co-SPACE. Those who consent to SPARKLE will be randomised 1:1 to either <italic>Parent Positive</italic> or Follow-up As Usual (FAU).</p>
                </sec>
                <sec>
                  <title>Participants</title>
                  <p id="Par3">Co-SPACE (a UK-wide longitudinal cohort study) parents aged ≥18 who have children aged 4-10 years will be eligible for SPARKLE.</p>
                </sec>
                <sec>
                  <title>Intervention and comparator</title>
                  <p id="Par4"><bold><italic>Parent Positive:</italic></bold> is a digital public health intervention that can be delivered rapidly at scale to support parents in managing their children’s behaviour to reduce conduct problems and levels of family conflict, which were exacerbated during the first lockdown, and which may increase further in future months as families need to cope with continuous uncertainty and further disruption to their daily lives. Co-designed with parents and based on decades of parenting research, <italic>Parent Positive</italic> consists of three elements: (i) Parenting Boosters: where advice, delivered in the form of narrated animations, videos, graphics and text is provided to help parents with eight common parenting challenges; (ii) Parenting Exchange: a facilitated parent-to-parent communication and peer support platform and; (iii) Parent Resources: giving access to carefully selected high-quality, evidence-based online parenting resources.</p>
                  <p id="Par5"><bold><italic>Follow-up as Usual:</italic></bold> FAU was selected as a comparator because the public health nature meant that an active comparator was not appropriate due to the pragmatic, rapid implementation of the trial. Individuals randomised to FAU will receive no intervention for the first two months while the data for baseline (T1), T2 and T3 are collected. They will then be given full access to the app until 30th November 2021.</p>
                </sec>
                <sec>
                  <title>Main outcomes</title>
                  <p id="Par6">Outcome measures will be collected remotely through Qualtrics according to the Co-SPACE schedule at baseline (T1), which will be the Co-SPACE survey data obtained immediately prior to randomisation, and then at one month (T2) and two months (T3) post-randomisation. Measures will be collected to assess group differences in child and parent outcomes, costs and service utilisation, and adverse events. Usage of Parent Positive will also be tracked. The primary outcome is parent-reported child conduct problems at one-month post-randomisation measured using the Strengths and Difficulties Questionnaire conduct problems subscale.</p>
                </sec>
                <sec>
                  <title>Randomisation</title>
                  <p id="Par7">Enrolled participants will be allocated to <italic>Parent Positive</italic> or FAU at the ratio of 1:1 by simple randomisation using the Randomizer function within the Qualtrics programme. Neither blocking nor stratification will be used.</p>
                </sec>
                <sec>
                  <title>Blinding (masking)</title>
                  <p id="Par8">It is not possible to blind parents enrolled in the study and Qualtrics will automatically inform parents of their group allocation. Blinded members of the research team and the senior statistician will not be given access to the Qualtrics system or the data in order to remain blinded until after the analysis is complete. We do not anticipate any serious harms associated with taking part in the intervention, therefore there will be no need to unblind any blinded staff during the study. The junior statistician will be unblinded throughout.</p>
                </sec>
                <sec>
                  <title>Numbers to be randomised (sample size)</title>
                  <p id="Par9">A total of 616 will be recruited into the trial with 308 consenting parents randomised to each treatment arm.</p>
                </sec>
                <sec>
                  <title>Trial status</title>
                  <p id="Par10">V1.0; 15.03.2021. Not yet recruiting. Anticipated start date: 1<sup>st</sup> April 2021. Anticipated end date for recruitment: 31<sup>st</sup> July 2021.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par11">Clinicaltrial.gov: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04786080">NCT04786080</ext-link>. The trial was prospectively registered on 8 March 2021.</p>
                </sec>
                <sec>
                  <title>Full protocol</title>
                  <p id="Par12">The full protocol is attached as an additional file, accessible from the Trials website (Additional file <xref rid="MOESM1" ref-type="media">1</xref>). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol. The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines (Additional file <xref rid="MOESM2" ref-type="media">2</xref>).</p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1186/s13063-021-05226-4.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>COVID-19</kwd>
                <kwd>Randomised controlled trial</kwd>
                <kwd>Protocol</kwd>
                <kwd>Child behaviour problems</kwd>
                <kwd>Parenting</kwd>
                <kwd>Intervention</kwd>
                <kwd>Digital health</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000269</institution-id>
                      <institution>Economic and Social Research Council</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>ES/V016393/1</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Sonuga-Barke</surname>
                      <given-names>Edmund J. S.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>United Kingdom Research and Innovation</institution>
                  </funding-source>
                  <award-id>2004CQ002/BS3</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Creswell</surname>
                      <given-names>Cathy</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>Westminster Foundation</institution>
                  </funding-source>
                  <award-id>-</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Creswell</surname>
                      <given-names>Cathy</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec1">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="13063_2021_5226_MOESM1_ESM.docx">
                      <caption>
                        <p><bold>Additional file 1.</bold> Full Study Protocol.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                  <supplementary-material content-type="local-data" id="MOESM2">
                    <media xlink:href="13063_2021_5226_MOESM2_ESM.doc">
                      <caption>
                        <p><bold>Additional file 2.</bold> SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher’s Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>The Maudsley Charity for their support in funding the original Families Under Pressure animations.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors’ contributions</title>
              <p>ESB, KKA, CC, SB, KG and PW obtained the funding for the trial. All authors contributed to the development of the protocol for the trial and read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>SPARKLE: Grant ES/V016393/1 from the Economic and Social Research Council, UK. Co-SPACE: Grant 2004CQ002/BS3 from the UKRI and Grant from the Westminster Foundation. The sponsors and funders played no role in the trial design.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>On completion of the study a clean, anonymised data set will be made available for open access via the UK Data Service or another suitable repository.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethics approval and consent to participate</title>
                <p id="Par13">Ethical approval has been granted by King’s College London – Psychiatry, Nursing and Midwifery Research Ethics Subcommittee, reference number HR-20/21-21451 and the University of Oxford Central University Research Ethics Committee, reference numbers R73153/RE001 for SPARKLE. Any future protocol amendments will be documented and submitted for ethical approval prior to implementation. No recruitment activity took place before ethical approval for the study had been obtained.</p>
                <p id="Par14">All Co-SPACE parents will have already given consent to take part in Co-SPACE through Qualtrics. Co-SPACE ethical approval was granted by the University of Oxford Central University Research Ethics Committee, reference numbers R69060/RE001. Those who respond to the invitation to participate in SPARKLE will be re-directed to SPARKLE's online Participant Information Sheet (PIS) within Qualtrics for more information. Before a parent enters a study, they will be asked to complete the informed consent form provided electronically within Qualtrics.</p>
              </notes>
              <notes id="FPar2">
                <title>Consent for publication</title>
                <p id="Par15">Not applicable.</p>
              </notes>
              <notes id="FPar3" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par16">ESB, KKA, MP, CD, OR, MK and PS developed the Parent Positive with digital design partner TOAD (<ext-link ext-link-type="uri" xlink:href="https://www.toadlondon.com/">https://www.toadlondon.com/</ext-link>). ESB has received speaker fees, consultancy or research funding from Takeda, Neurotech Solutions, QBtech and Medice. He has received royalties from the New Forest Parenting Programme.</p>
                <p id="Par17">KG’s contributions represent independent research part funded by the NIHR Biomedical Research Centre (South London and Maudsley NHS Foundation Trust and King’s College London) and the NIHR Applied Research Collaboration South London (King’s College Hospital NHS Foundation Trust). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health and Social Care or The Stroke Association.</p>
              </notes>
            </notes>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
